More than 130,000 Kaiser Permanente members in Northern California are sharing their spit to have their genomes scanned, reports the New York Times. This study aims to "uncover the genetic roots of chronic disease and, perhaps, to find out why some people live longer than others," the Times says, as participants' genetic information will be linked to their medical information (though their names will be removed from the data).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.